A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

NCT00000791 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Glycovir
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]